1. Dihydroxyphenylglycol as a biomarker of norepinephrine transporter inhibition by atomoxetine human model to assess central and peripheral effects of dosing;Bieck;J. Clin. Psychopharmacol.,2016
2. Attention-deficit/hyperactivity disorder: a selective overview;Biederman;Biol. Psychiatry,2005
3. Dopamine in the hippocampus is cleared by the norepinephrine transporter;Borgkvist;Int J. Neuropsychopharmacol.,2012
4. A review of pharmacological management of attention-deficit/hyperactivity disorder;Briars;J. Pedia Pharm. Ther.,2016
5. Cheetham S.C., Jagger L., Viggers J., Slater N., Liu S., Molino B. and Sargent B. (2005). Ex vivo occupancy as a technique to assess drug actions at multiple targets. Society for Neuroscience Meeting, Washington, DC, USA. Program No. 4476.